Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000473542 | SCV000554950 | likely benign | Neurofibromatosis, type 1 | 2024-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000563397 | SCV000662909 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586902 | SCV000696399 | likely benign | not specified | 2019-08-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001533943 | SCV001750823 | likely benign | not provided | 2020-09-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 10980545) |
Genome- |
RCV000473542 | SCV002560834 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |